Kymera Therapeutics, Inc. (KYMR) Financials
KYMR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 868.3 million | 157.0 million |
| 2023-12-31 | 575.8 million | 180.8 million |
| 2023-09-30 | 552.4 million | 156.8 million |
| 2023-06-30 | 581.9 million | 146.5 million |
KYMR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -47.0 million | 12.0 million |
| 2023-12-31 | -3.6 million | 10.9 million |
| 2023-09-30 | -39.7 million | 11.7 million |
| 2023-06-30 | -46.0 million | 11.2 million |
KYMR Net Income
No data available :(
KYMR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 520.5 million | - | 87.0 million |
| 2023-12-31 | 374.9 million | - | 84.7 million |
| 2023-09-30 | 357.8 million | - | 80.8 million |
| 2023-06-30 | 367.6 million | - | 75.1 million |
KYMR Shares Outstanding
KYMR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 7.4 million | 48.8 million | 14.4 million | - |
| 2023-12-31 | 11.6 million | 53.0 million | 14.2 million | - |
| 2023-09-30 | 8.1 million | 48.1 million | 14.1 million | - |
| 2023-06-30 | 10.8 million | 45.8 million | 14.1 million | - |
KYMR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 10.3 million | 1.5 million |
| 2023-12-31 | 47.9 million | 865000 |
| 2023-09-30 | 4.7 million | 900000 |
| 2023-06-30 | 16.5 million | 900000 |
KYMR
Price: $37.94
52 week price:
Earnings Per Share: -2.52 USD
P/E Ratio: -13.01
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 492600
Market Capitalization: 2.3 billion